Docket Nexus — Federal court records.
Antitrust Lawsuit

Dao Pharmacy Inc v. Goodrx, Inc

Antitrust Terminated 04/25/2025 District Court, E.D. Pennsylvania

Dao Pharmacy Inc v. Goodrx, Inc is a federal antitrust lawsuit filed on 04/09/2025 in the District Court, E.D. Pennsylvania. The case was terminated on 04/25/2025.

Court
District Court, E.D. Pennsylvania (E.D. Pa.)
Official Court Website →
Assigned judge
Gail A Weilheimer · 28 cases in index
Docket number
2:25-cv-01829
Cause
28:1331 Fed. Question: Anti-trust
28 U.S.C. § 1331 — Federal question jurisdiction
Nature of suit
410 Other Statutes: Anti-Trust
Claims of unlawful restraint of trade, monopolization, or anticompetitive conduct under the Sherman and Clayton Acts.
Jurisdiction
Federal Question
Jury demand
Plaintiff
Date filed
04/09/2025
Date terminated
04/25/2025

1,619 Antitrust cases in this court are indexed here.

Parties

Part of a Larger Litigation Pattern

This is one of 23 Antitrust cases in our index naming GoodRX Inc — a possible mass-tort or coordinated-litigation cluster.

About Antitrust Lawsuits

Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

Frequently Asked Questions

What is Dao Pharmacy Inc v. Goodrx, Inc?

Dao Pharmacy Inc v. Goodrx, Inc is a federal antitrust lawsuit filed on 04/09/2025 in the District Court, E.D. Pennsylvania. The case was terminated on 04/25/2025. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What type of case is this?

It is classified as “Antitrust” under the federal nature-of-suit system. Antitrust lawsuits allege unlawful restraints on competition — price-fixing, monopolization, market allocation, or anticompetitive mergers — brought under federal antitrust statutes such as the Sherman and Clayton Acts.

What court is the case in?

The case is in the District Court, E.D. Pennsylvania, docket number 2:25-cv-01829.

When was the case filed?

Dao Pharmacy Inc v. Goodrx, Inc was filed on 04/09/2025. It was terminated on 04/25/2025.

What law is the case brought under?

The docket lists the cause as 28 U.S.C. § 1331 — Federal question jurisdiction.

Other Cases Involving These Parties

Related Antitrust Cases

Source: public U.S. federal court record (docket 69865780).